Search

Your search keyword '"Stögmann, E."' showing total 91 results

Search Constraints

Start Over You searched for: Author "Stögmann, E." Remove constraint Author: "Stögmann, E."
91 results on '"Stögmann, E."'

Search Results

11. Analysis of shared heritability in common disorders of the brain

13. Analysis of shared heritability in common disorders of the brain

15. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.

23. Analysis of shared heritability in common disorders of the brain

24. Antiplatelet therapy is not associated with increased risk of complications after lumbar puncture.

25. Aβ status assessment in a hypothetical scenario prior to treatment with disease-modifying therapies: Evidence from 10-year real-world experience at university memory clinics.

26. A digitally supported multimodal lifestyle program to promote brain health among older adults (the LETHE randomized controlled feasibility trial): study design, progress, and first results.

27. Amyloid-beta antibody treatment in Alzheimer's disease : An update on recent data and outlook on implementation in clinical routine.

28. Monoclonal anti-amyloid antibody treatment: the epidemiological profile of the target patients in Austria and the status of treatment-eligible patients registered at an outpatient memory clinic.

29. Predictive value of somatic and functional variables for cognitive deterioration for early-stage patients with Alzheimer's Disease: Evidence from a prospective registry on dementia.

30. Real-world performance of plasma p-tau181 in a heterogeneous memory clinic cohort.

31. Serum Markers of Neurodegeneration Are Strongly Linked to Heart Failure Severity and Outcome.

32. Clinical heterogeneity within the ALS-FTD spectrum in a family with a homozygous optineurin mutation.

33. Olfactory identification, cognition, depressive symptoms, and 5-year mortality in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease.

34. Heightened Prevalence of Common Hospital-Treated Infections Preceding Dementia Diagnosis with Accelerated Dementia Onset after Influenza.

35. Usability testing of the first prototype of the Memento system: a technological device to promote an independent living in people with dementia.

37. No Association of Multiple Sclerosis with C9orf72 Hexanucleotide Repeat Size in an Austrian Cohort.

38. Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genes.

39. Analysis of co-medication in people with dementia.

40. Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy.

41. Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study.

42. C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients.

43. Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer's disease.

44. User experience and acceptance of a device assisting persons with dementia in daily life: a multicenter field study.

45. Mapping genomic loci implicates genes and synaptic biology in schizophrenia.

46. No effect of thyroid hormones on 5-year mortality in patients with subjective cognitive decline, mild cognitive disorder, and Alzheimer's disease.

47. Serum NfL in Alzheimer Dementia: Results of the Prospective Dementia Registry Austria.

48. Reduction of physical activity during the COVID-19 pandemic is related to increased neuropsychiatric symptoms in memory clinic patients.

49. Individual cognitive changes in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease using the reliable change index methodology.

50. Genetics of Alzheimer's disease.

Catalog

Books, media, physical & digital resources